Further immunization studies with mammary tumor virus

Area of Science:

• Virology
• Immunology
• Oncology

Background:

• Murine mammary tumor virus (MMTV) is an endogenous retrovirus linked to mammary cancer in mice.
• Understanding MMTV's role in tumorigenesis is crucial for developing preventative strategies.

Purpose of the Study:

• To evaluate the efficacy of a formalin-inactivated MMTV vaccine in preventing viral expression and mammary tumorigenesis.
• To assess vaccine protection against MMTV challenge in a mouse model.

Main Methods:

• Administration of a single intramuscular dose of formalin-inactivated MMTV to different mouse strains.
• Monitoring viral expression and mammary tumor incidence in vaccinated and control groups.
• Challenging vaccinated C57BL mice with live RIII MMTV and assessing protection.

Main Results:

• Vaccination significantly reduced mammary tumor incidence in Af mice (39%) and RIIIf mice (11%) carrying endogenous MMTV.
• A 1 µg dose of the vaccine in Freund's complete adjuvant conferred protection against RIII MMTV challenge in C57BL mice.

Conclusions:

• Formalin-inactivated MMTV vaccination is effective in reducing viral expression and mammary tumorigenesis.
• This vaccine holds potential as a prophylactic measure against MMTV-induced mammary cancer.